CLINICAL CRITERIA FOR DRUG SELECTION IN THE TREATMENT OF VIRAL INFECTIONS IN CHILDREN

O`ktamova N.B

Tashkent City Alfraganus University Faculty of Medicine, General Medicine Program 3rd-year Student

Boymuratov F.T

Tashkent City Alfraganus University Faculty of Medicine, Department of Pharmacy and Chemistry Associate Professor

Keywords: Keywords: Children; viral infections; antiviral therapy; drug selection; clinical criteria; pediatric pharmacology; rational pharmacotherapy.

---

Abstract

Abstract: Viral infections are among the most common causes of morbidity in the pediatric population and represent a major challenge for clinicians worldwide. The selection of appropriate antiviral or supportive therapy in children requires careful consideration of several clinical criteria, including the type of virus, age-related pharmacokinetics, immune status, and potential drug toxicity. Since many viral infections are self-limiting, unnecessary medication use—particularly antibiotics—should be avoided. Rational drug selection must balance therapeutic efficacy and safety while minimizing adverse reactions and resistance development. This study reviews the main clinical factors that influence drug choice in pediatric viral infections and emphasizes the importance of evidence-based, individualized pharmacotherapy to ensure optimal outcomes and reduce complications.

---

References

1. Kimberlin, D. W., & Barnett, E. D. (2021). Red Book: 2021–2024 Report of the Committee on Infectious Diseases. American Academy of Pediatrics.

2. Principi, N., & Esposito, S. (2016). Antiviral therapy for pediatric viral infections: A review. Current Opinion in Pediatrics, 28(1), 97–102.

3. Grohskopf, L. A., Alyanak, E., Ferdinands, J. M., et al. (2022). Prevention and Control of Seasonal Influenza with Vaccines. MMWR Recommendations and Reports, 71(1), 1–24.

4. Sawyer, M. H. (2023). Antiviral drugs in pediatrics: Clinical use and safety considerations. Journal of Pediatric Pharmacology and Therapeutics, 28(4), 210–222.

5. Kliegman, R. M., St. Geme, J. W., Blum, N. J., et al. (2020). Nelson Textbook of Pediatrics. 21st Edition, Elsevier.

6. World Health Organization (2021). Clinical management of severe acute respiratory infections when novel coronavirus infection is suspected. WHO Guidelines.

7. Jackson, M. A., & Schutze, G. E. (2019). The use and misuse of antibiotics in pediatrics. Pediatrics, 143(3), e20192724.

8. Aranda, J. V., & Beharry, K. D. (2017). Pharmacokinetics and pharmacodynamics in neonates and children. Pediatric Clinics of North America, 64(6), 1203–1222.

9. Fiore, A. E., Fry, A., Shay, D., et al. (2011). Antiviral agents for the treatment and chemoprophylaxis of influenza. MMWR Recommendations and Reports, 60(1), 1–24.

10. Pavia, A. T. (2020). Viral infections in immunocompromised children: Current management and challenges. Pediatric Infectious Disease Journal, 39(12), 1087–1094.